BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23922608)

  • 1. Role of gender in the survival of surgical patients with nonsmall cell lung cancer.
    Scaglia NC; Chatkin JM; Pinto JA; Tsukazan MT; Wagner MB; Saldanha AF
    Ann Thorac Med; 2013 Jul; 8(3):142-7. PubMed ID: 23922608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a gender difference in non-small cell lung cancer survival?
    Chatkin JM; Abreu CM; Fritscher CC; Wagner MB; Pinto JA
    Gend Med; 2004 Aug; 1(1):41-7. PubMed ID: 16115582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
    Birim O; Kappetein AP; Bogers AJ
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are there radiographic, metabolic, and prognostic differences between cavitary and noncavitary nonsmall cell lung carcinoma? A retrospective fluorodeoxyglucose positron emission tomography/computed tomography study.
    Nguyen NC; Abhishek K; Nyon S; Farghaly HR; Osman MM; Reimers HJ
    Ann Thorac Med; 2016; 11(1):49-54. PubMed ID: 26933457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender influence on weight-loss pattern and survival of nonsmall cell lung carcinoma patients.
    Palomares MR; Sayre JW; Shekar KC; Lillington LM; Chlebowski RT
    Cancer; 1996 Nov; 78(10):2119-26. PubMed ID: 8918405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumonectomy for stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival.
    Alexiou C; Beggs D; Onyeaka P; Kotidis K; Ghosh S; Beggs L; Hopkinson DN; Duffy JP; Morgan WE; Rocco G
    Ann Thorac Surg; 2003 Oct; 76(4):1023-8. PubMed ID: 14529978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.
    Visbal AL; Williams BA; Nichols FC; Marks RS; Jett JR; Aubry MC; Edell ES; Wampfler JA; Molina JR; Yang P
    Ann Thorac Surg; 2004 Jul; 78(1):209-15; discussion 215. PubMed ID: 15223430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer?
    McGovern SL; Liao Z; Bucci MK; McAleer MF; Jeter MD; Chang JY; O'Reilly MS; Cox JD; Allen PK; Komaki R
    Cancer; 2009 Jul; 115(14):3233-42. PubMed ID: 19472405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring Stage I non-small-cell lung cancer: development of a prognostic model predicting 5-year survival after surgical resection†.
    Guerrera F; Errico L; Evangelista A; Filosso PL; Ruffini E; Lisi E; Bora G; Asteggiano E; Olivetti S; Lausi P; Ardissone F; Oliaro A
    Eur J Cardiothorac Surg; 2015 Jun; 47(6):1037-43. PubMed ID: 25391390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study.
    Sakurai H; Asamura H; Goya T; Eguchi K; Nakanishi Y; Sawabata N; Okumura M; Miyaoka E; Fujii Y;
    J Thorac Oncol; 2010 Oct; 5(10):1594-601. PubMed ID: 20736855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery.
    Caglar HB; Baldini EH; Othus M; Rabin MS; Bueno R; Sugarbaker DJ; Mentzer SJ; Jänne PA; Johnson BE; Allen AM
    Cancer; 2009 Sep; 115(18):4156-66. PubMed ID: 19551884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Improvement in 2-Year Survival Rate of Patients with Stage II-III Non-Small Cell Lung Cancer Treated with Different Durations of Chinese Patent Medicine: A Retrospective Cohort Study.
    Wang L; Jia K; Li F; Zhang C; Feng G; Du J
    Front Pharmacol; 2021; 12():719802. PubMed ID: 34539404
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex-Dependent Staging in Non-Small-Cell Lung Cancer; Analysis of the Effect of Sex Differences in the Eighth Edition of the Tumor, Node, Metastases Staging System.
    Wainer Z; Wright GM; Gough K; Daniels MG; Russell PA; Choong P; Conron M; Ball D; Solomon B
    Clin Lung Cancer; 2018 Nov; 19(6):e933-e944. PubMed ID: 30206043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of gender on the prognosis of patients with non-small cell lung cancer].
    Xu QP; He F; Liu ZQ; Xiong WM; Lin JB; Cai L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):244-247. PubMed ID: 28231675
    [No Abstract]   [Full Text] [Related]  

  • 16. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence.
    Harpole DH; Herndon JE; Young WG; Wolfe WG; Sabiston DC
    Cancer; 1995 Sep; 76(5):787-96. PubMed ID: 8625181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL14 and NOS1 expression in specimens from patients with stage I-IIIA nonsmall cell lung cancer after curative resection.
    Ji X; Shen Z; Zhao B; Yuan X; Zhu X
    Medicine (Baltimore); 2018 Mar; 97(10):e0101. PubMed ID: 29517684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive and prognostic impact of primary tumor-bearing lobe in nonsmall cell lung cancer patients treated with anti-PD-1 therapy.
    Takamori S; Takada K; Shimokawa M; Matsubara T; Haratake N; Miura N; Toyozawa R; Yamaguchi M; Takenoyama M; Yoneshima Y; Tanaka K; Okamoto I; Tagawa T; Mori M
    Int J Cancer; 2020 Oct; 147(8):2327-2334. PubMed ID: 32356560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
    Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
    Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined analysis of cyclooxygenase-2 expression with p53 and Ki-67 in nonsmall cell lung cancer.
    Tsubochi H; Sato N; Hiyama M; Kaimori M; Endo S; Sohara Y; Imai T
    Ann Thorac Surg; 2006 Oct; 82(4):1198-204. PubMed ID: 16996907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.